Abstract P1-17-01: Response of persistent metastatic ER+/Her2- breast cancer treated with fulvestrant plus enzalutamideJennifer K. Richer, Anthony Elias, Rosa I. Gallagher et al.|Cancer Research|2022Cited by 1
Abstract CT144: Randomized phase II trial of preoperative fulvestrant with or without enzalutamide for ER+/Her2- breast cancerAnthony Elias, Jennifer K. Richer, Alyse Staley et al.|Cancer Research|2023Cited by 0